Molecular Diagnostics-United States Market Status and Trend Report 2013-2023
Report Summary
Molecular Diagnostics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in United States, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the United States Molecular Diagnostics market as:
United States Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Infectious Disease
Oncology
Genetics
Microbiology
United States Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Laboratories
United States Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Diagnostics
QIAGEN N.V.
Hologic Inc
Grifols
Abbott Laboratories
Siemens Healthcare
Becton, Dickinson
Beckman Coulter
bioM?rieux SA
Cepheid
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Molecular Diagnostics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in United States, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the United States Molecular Diagnostics market as:
United States Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Infectious Disease
Oncology
Genetics
Microbiology
United States Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Laboratories
United States Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Diagnostics
QIAGEN N.V.
Hologic Inc
Grifols
Abbott Laboratories
Siemens Healthcare
Becton, Dickinson
Beckman Coulter
bioM?rieux SA
Cepheid
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MOLECULAR DIAGNOSTICS
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 Infectious Disease
1.2.2 Oncology
1.2.3 Genetics
1.2.4 Microbiology
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Hospital
1.3.2 Laboratories
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 United States Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Diagnostics in United States 2013-2017
2.2 Consumption Market of Molecular Diagnostics in United States by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in United States by Regions
2.2.2 Revenue of Molecular Diagnostics in United States by Regions
2.3 Market Analysis of Molecular Diagnostics in United States by Regions
2.3.1 Market Analysis of Molecular Diagnostics in New England 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in The Midwest 2013-2017
2.3.4 Market Analysis of Molecular Diagnostics in The West 2013-2017
2.3.5 Market Analysis of Molecular Diagnostics in The South 2013-2017
2.3.6 Market Analysis of Molecular Diagnostics in Southwest 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in United States 2018-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in United States 2018-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in United States by Types
3.1.2 Revenue of Molecular Diagnostics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Molecular Diagnostics in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Diagnostics in United States by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in New England
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Molecular Diagnostics by Downstream Industry in The West
4.2.5 Demand Volume of Molecular Diagnostics by Downstream Industry in The South
4.2.6 Demand Volume of Molecular Diagnostics by Downstream Industry in Southwest
4.3 Market Forecast of Molecular Diagnostics in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR DIAGNOSTICS
5.1 United States Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Molecular Diagnostics in United States by Major Players
6.2 Revenue of Molecular Diagnostics in United States by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche Diagnostics
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.2 QIAGEN N.V.
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.3 Hologic Inc
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.4 Grifols
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Siemens Healthcare
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.7 Becton, Dickinson
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson
7.8 Beckman Coulter
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.9 bioM?rieux SA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioM?rieux SA
7.10 Cepheid
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR DIAGNOSTICS
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR DIAGNOSTICS
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 Infectious Disease
1.2.2 Oncology
1.2.3 Genetics
1.2.4 Microbiology
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Hospital
1.3.2 Laboratories
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 United States Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Diagnostics in United States 2013-2017
2.2 Consumption Market of Molecular Diagnostics in United States by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in United States by Regions
2.2.2 Revenue of Molecular Diagnostics in United States by Regions
2.3 Market Analysis of Molecular Diagnostics in United States by Regions
2.3.1 Market Analysis of Molecular Diagnostics in New England 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in The Midwest 2013-2017
2.3.4 Market Analysis of Molecular Diagnostics in The West 2013-2017
2.3.5 Market Analysis of Molecular Diagnostics in The South 2013-2017
2.3.6 Market Analysis of Molecular Diagnostics in Southwest 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in United States 2018-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in United States 2018-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in United States by Types
3.1.2 Revenue of Molecular Diagnostics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Molecular Diagnostics in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Diagnostics in United States by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in New England
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Molecular Diagnostics by Downstream Industry in The West
4.2.5 Demand Volume of Molecular Diagnostics by Downstream Industry in The South
4.2.6 Demand Volume of Molecular Diagnostics by Downstream Industry in Southwest
4.3 Market Forecast of Molecular Diagnostics in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR DIAGNOSTICS
5.1 United States Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Molecular Diagnostics in United States by Major Players
6.2 Revenue of Molecular Diagnostics in United States by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche Diagnostics
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.2 QIAGEN N.V.
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.3 Hologic Inc
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.4 Grifols
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Siemens Healthcare
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.7 Becton, Dickinson
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson
7.8 Beckman Coulter
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.9 bioM?rieux SA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioM?rieux SA
7.10 Cepheid
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR DIAGNOSTICS
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR DIAGNOSTICS
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
